Trademark: 88361359
Word
ATHIRA PHARMA
Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
88361359
Registration Number
7236685
Registration Date
Tuesday, December 5, 2023
Mark Type
4000
Filing Date
Thursday, March 28, 2019
Published for Opposition
Tuesday, September 8, 2020

Trademark Owner History
Athira Pharma, Inc. - Original Registrant

Classifications
5 Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
"PHARMA"

Trademark Events
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Nov 1, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 31, 2023
Allowed Principal Register - Sou Accepted
May 11, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
May 11, 2023
Teas Change Of Correspondence Received
May 11, 2023
Teas Change Of Owner Address Received
May 10, 2023
Statement Of Use Processing Complete
Apr 20, 2023
Use Amendment Filed
May 8, 2023
Case Assigned To Intent To Use Paralegal
Apr 20, 2023
Teas Statement Of Use Received
Apr 18, 2023
Sou Teas Extension Received
Oct 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 13, 2022
Sou Extension 4 Granted
Oct 13, 2022
Sou Extension 4 Filed
Oct 13, 2022
Sou Teas Extension Received
Mar 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 24, 2022
Sou Extension 3 Granted
Mar 24, 2022
Sou Extension 3 Filed
Mar 24, 2022
Sou Teas Extension Received
Sep 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2021
Sou Extension 2 Granted
Sep 13, 2021
Sou Extension 2 Filed
Sep 13, 2021
Sou Teas Extension Received
May 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2021
Sou Extension 1 Granted
Apr 29, 2021
Sou Extension 1 Filed
Apr 29, 2021
Sou Teas Extension Received
Nov 3, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 8, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 8, 2020
Published For Opposition
Aug 19, 2020
Notification Of Notice Of Publication E-Mailed
Aug 4, 2020
Exparte Appeal Terminated
Aug 4, 2020
Approved For Pub - Principal Register
Jul 29, 2020
Teas/Email Correspondence Entered
Jul 29, 2020
Correspondence Received In Law Office
Jul 29, 2020
Assigned To Lie
Jul 15, 2020
Teas Request For Reconsideration Received
Jul 15, 2020
Ex Parte Appeal-Instituted
Jul 15, 2020
Jurisdiction Restored To Examining Attorney
Jul 15, 2020
Exparte Appeal Received At Ttab
Jan 15, 2020
Notification Of Final Refusal Emailed
Jan 15, 2020
Final Refusal E-Mailed
Jan 15, 2020
Final Refusal Written
Dec 12, 2019
Teas/Email Correspondence Entered
Dec 11, 2019
Correspondence Received In Law Office
Dec 11, 2019
Teas Response To Office Action Received
Jun 12, 2019
Notification Of Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action Written
Jun 7, 2019
Assigned To Examiner
Apr 16, 2019
New Application Office Supplied Data Entered
Apr 1, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24